Valuation: ALTEOGEN Inc.

Market Cap 18,292B 11.95B 10.45B 9.6B 8.95B 16.97B 1,138B 17.23B 115B 44.81B 559B 44.86B 43.89B 1,927B P/E 2026 *
62.5x
P/E 2027 * 41.9x
Enterprise Value 17.79B 11.62M 10.16M 9.34M 8.71M 16.51M 1.11B 16.76M 112M 43.59M 544M 43.63M 42.7M 1.87B EV / Sales 2026 *
38x
EV / Sales 2027 * 26x
Free-Float
74.26%
Yield 2026 *
0.15%
Yield 2027 * 0.16%
1 day-2.84%
1 week-8.93%
Current month-5.40%
1 month-4.34%
3 months-2.98%
6 months-25.27%
Current year-24.03%
1 week 331,000
Extreme 331000
385,500
1 month 286,000
Extreme 286000
397,500
Current year 286,000
Extreme 286000
529,000
1 year 286,000
Extreme 286000
569,000
3 years 38,000
Extreme 38000
569,000
5 years 27,875
Extreme 27875
569,000
10 years 3,645.83
Extreme 3645.8333
569,000
Manager TitleAgeSince
Chief Executive Officer 60 2025-12-25
Director of Finance/CFO 61 2023-03-27
Corporate Officer/Principal - -
Director TitleAgeSince
Chairman 71 2008-05-12
Director/Board Member 70 2021-03-28
Director/Board Member 61 2023-03-27
Date Insider Type Main position Quantity % Market Cap.
25-05-20Fiscal year

Chief Executive Officer

7,200 0.0135%
24-03-26Sell 1,600,000 3.0182%
24-01-04Sell 6,000 0.0115%
Change 5-day change 1-year change 3-year change Capi.($)
-2.84%-8.93%-12.99%+695.11% 12.22B
+4.73%+5.50%+19.45%-8.94% 66.56B
-1.93%+0.39%+58.62%+226.33% 57.64B
+1.07%+42.10%+42.10%+42.10% 42.24B
+3.45%+3.54%-49.20%-56.09% 39.09B
-4.05%+7.01%+62.26%-24.13% 31.91B
-1.99%+33.49%+163.41%-34.35% 31.65B
-0.28%+8.68%+71.42%+87.73% 23.35B
+2.87%+15.37%+10.72%+196.62% 18.92B
-0.13%+2.75%+67.48%+130.07% 17.17B
Average +2.30%+5.80%+43.33%+125.44% 34.08B
Weighted average by Cap. +2.57%+5.96%+42.72%+78.28%

Financials

2026 *2027 *
Net sales 469B 306M 268M 246M 229M 435M 29.16B 442M 2.95B 1.15B 14.33B 1.15B 1.12B 49.39B 672B 439M 384M 353M 329M 624M 41.81B 633M 4.24B 1.65B 20.55B 1.65B 1.61B 70.82B
Net income 311B 203M 177M 163M 152M 288M 19.33B 293M 1.96B 761M 9.5B 762M 746M 32.74B 397B 259M 226M 208M 194M 368M 24.67B 374M 2.5B 971M 12.13B 973M 952M 41.79B
Net Debt -499B -326M -285M -262M -244M -463M -31.03B -470M -3.14B -1.22B -15.25B -1.22B -1.2B -52.56B -828B -541M -473M -434M -405M -768M -51.48B -780M -5.22B -2.03B -25.31B -2.03B -1.99B -87.21B
Logo ALTEOGEN Inc.
Alteogen Inc is a Korea-based company primarily engaged in the research, development, and sales of biopharmaceuticals. The Company develops, produces, and sells biopharmaceuticals, including biobetters and novel biopharmaceuticals, based primarily on hyaluronidase protein engineering technology, sustained-release biopharmaceutical technology, and next-generation antibody-drug conjugate technology. In addition, the Company is engaged in research, development, and commercialization of biosimilars.
Employees
172
Date Price Change Volume
26-07-02 341,500.00 -2.84% 439,497
26-07-02 ₩351,500.00 -1.82% 392,958
26-07-01 ₩358,000.00 -0.83% 439,869
26-06-30 ₩361,000.00 -3.22% 432,302
26-06-29 ₩373,000.00 +8.59% 686,307
Trader
Investor
Global
Quality
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
341,500.00KRW
Average target price
458,000.00KRW
Spread / Average Target
+34.11%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A196170 Stock